INTERNATIONAL PATENT: MAZE THERAPEUTICS, INC. FILES APPLICATION FOR "INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF"

GENEVA, March 10 -- MAZE THERAPEUTICS, INC. (171 Oyster Point Blvd, Suite 300South San Francisco, California 94080) filed a patent application (PCT/US2024/044223) for "INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF" on Aug 28, 2024. With publication no. WO/2025/049604, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PITZEN, Jennifer (c/o Maze Therapeutics, Inc.171 Oyster Point Blvd, Suite 300South San Francisco, California 94080), ZIEBENHAUS, Chris (c/o Maze Therapeutics, Inc.171 Oys...